Back
Xylem Vs. Dave Industry Stock Comparison
Sell
39
XYL
Xylem
Last Price:
$130.95
Seasonality Move:
0.98%
Buy
65
DAVE
Dave
Last Price:
$100.69
Seasonality Move:
-2.23%
Sell
39
Xylem (XYL)
is a Sell
Is Xylem a Buy, Sell or Hold?
-
XYL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DAVE Stock Price Chart
XYL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.78 | Buy |
Relative Strength Index (14 RSI): | 57.06 | Buy |
Chaikin Money Flow: | -12096 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.23 | Buy |
Relative Strength Index (14 RSI): | 49.59 | Sell |
Chaikin Money Flow: | 296231 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
XYL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.07 | Sell |
20-day SMA: | 128.41 | Buy |
50-day SMA: | 122.35 | Buy |
200-day SMA: | 130.75 | Sell |
8-day EMA: | 128.88 | Sell |
20-day EMA: | 127.71 | Buy |
50-day EMA: | 125.41 | Buy |
200-day EMA: | 126.05 | Buy |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 104.99 | Sell |
20-day SMA: | 104.31 | Sell |
50-day SMA: | 96.22 | Buy |
200-day SMA: | 58.36 | Buy |
8-day EMA: | 103 | Sell |
20-day EMA: | 102.6 | Sell |
50-day EMA: | 95.16 | Buy |
200-day EMA: | 65.4 | Buy |
Xylem Earnings Growth & XYL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.43 per share, and an increase next year of $0.58 per share.
Dave Earnings Growth & DAVE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $1.09 per share.
Xylem Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dave Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |